Detalhe da pesquisa
1.
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
Eur J Neurol
; 30(4): 920-933, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36692250
2.
Rare neurovascular genetic and imaging markers across neurodegenerative diseases.
Alzheimers Dement
; 19(12): 5583-5595, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37272523
3.
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS.
Am J Hum Genet
; 105(1): 151-165, 2019 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31230722
4.
Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients.
Mov Disord
; 37(6): 1304-1309, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35403259
5.
Caregiving concerns and clinical characteristics across neurodegenerative and cerebrovascular disorders in the Ontario neurodegenerative disease research initiative.
Int J Geriatr Psychiatry
; 37(6)2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35633037
6.
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Mov Disord
; 36(1): 106-117, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33002231
7.
Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 91(7): 695-702, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32303560
8.
Cerebrospinal Fluid Cytokines and Neurodegeneration-Associated Proteins in Parkinson's Disease.
Mov Disord
; 35(6): 1062-1066, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32413185
9.
Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities.
Mov Disord
; 35(11): 2090-2095, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32573853
10.
Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson's disease.
Brain Behav Immun
; 87: 473-488, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32006615
11.
Gut-brain axis and the spread of α-synuclein pathology: Vagal highway or dead end?
Mov Disord
; 34(3): 307-316, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30653258
12.
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
Mov Disord
; 34(12): 1839-1850, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31505070
13.
Sleep-related motor and behavioral disorders: Recent advances and new entities.
Mov Disord
; 33(7): 1042-1055, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29756278
14.
Neuroendocrine abnormalities in Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 88(2): 176-185, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27799297
15.
Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 88(8): 648-652, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28250029
16.
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease.
Mov Disord
; 31(7): 1062-6, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26971528
17.
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
Mov Disord
; 31(7): 995-1003, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-26999434
18.
Anti-collapsin response mediator protein 5 encephalitis masquerading as a low-grade brain tumour.
Pract Neurol
; 16(5): 376-80, 2016 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-27247429
19.
Toscana virus encephalitis following a holiday in Sicily.
Pract Neurol
; 16(2): 139-41, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26647398
20.
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Lancet
; 383(9923): 1138-46, 2014 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-24412048